Search - tctmd.com

Displaying 1 - 20 of 144

Sort: Relevancy | Date

News Conference News STS 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Yael L. Maxwell

January 27, 2025

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Conference News EHRA 2023

EPs Push for More Involvement in TAVI Heart Team Discussions

Michael O'Riordan

April 21, 2023

News Conference News EuroPCR 2022

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

Caitlin E. Cox

May 17, 2022

News Daily News

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

L.A. McKeown

November 30, 2021

News Daily News

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

Michael O'Riordan

October 01, 2021

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

Excluded from Pivotal Trials, Low-risk Complex Patients Warrant Caution

News Daily News

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

L.A. McKeown

January 22, 2021

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Caitlin E. Cox

September 14, 2020

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

L.A. McKeown

August 17, 2020

News Conference News CRT 2020

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

L.A. McKeown

February 24, 2020

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Caitlin E. Cox

August 27, 2019

Advertisement

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Top Structural Heart News of 2023

EPs Push for More Involvement in TAVI Heart Team Discussions

Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

Infective Endocarditis Rare After AVR, but Often a Killer When It Occurs

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

Excluded From Pivotal Trials, Low-risk Complex AS Patients Warrant Caution

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content